Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2018

View Archived Issues

Avillion enters agreement to develop PT-027 for asthma

First patient dosed in phase I study of Affibody's ABY-039

Merus said that Ono Pharmaceutical enter new research and license agreement

IL-32 isoforms tied to cardiovascular disease in HIV-infected individuals

Inovio Pharmaceuticals reports interim results from phase I study of DNA immunotherapy for HBV

FDA accepts IND for phase II study of SM-88 in pancreatic cancer

Jupiter Orphan Therapeutics submits IND in U.S. for Jotrol

Initiation of phase I trial to evaluate VLA-1553 vaccine candidate against Chikungunya

Savara begins OPTIMA study of Molgradex, ceases development of Aironite

OxThera initiates phase III study of Oxabact in primary hyperoxaluria

3BNC117 and 10-1074 antibody combination shows promise for HIV infection

Ionis opens enrollment in phase II trial of IONIS-FB-LRX in GA secondary to AMD

ImmunoRestoration enters license agreement with University of Pennsylvania

Medshine Discovery patents new PDE4 inhibitors

Arrowhead initiates phase I/IIa trial of ARO-HBV for hepatitis B

FDA accepts sBLA for Xeomin

Interim ANNEXA-4 data show high rate of hemostasis with andexanet alfa

Nanchang Helioeast Pharmaceutical presents novel TKIs

FDA places clinical hold on phase I/II trial of SGT-001 for Duchenne muscular dystrophy

CSL Behring studies safety of CSL-730 in healthy Caucasian and Japanese subjects

Japanese researchers disclose PDE7 inhibitors

FDA awards fast track designation to Destiny Pharma's exeporfinium chloride

University of Michigan discovers Bcr-Abl kinase inhibitors

3M Innovative Properties cytokine-production inducers

Exosome Diagnostics collaborates with Intezyne on assay for use in IT-139 trials

Novel AC5 inhibitor for treating myocardial infarction shows promise

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...